Influence of Diet and Gender on Plasma DPP4 Activity and GLP-1 in Patients with Metabolic Syndrome: An Experimental Pilot Study

Background: Glucagon-Like Peptide-1 (GLP-1) is hydrolyzed by Dipeptidyl-Peptidase 4 (DPP4), and several studies suggest that both GLP-1 and DPP4 inhibitors have potentially beneficial effects on cardiovascular risks. The objective of this study was to analyze the differences between plasma GLP-1 and...

詳細記述

書誌詳細

出版年:	Molecules
主要な著者:	Francisco Tomás Pérez-Durillo, Ana Belén Segarra, Ana Belén Villarejo, Manuel Ramírez-Sánchez, Isabel Prieto
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2018-06-01
主題:	metabolic syndrome glucagon-like peptide-1 dipeptidyl-peptidase 4 cardiovascular risk
オンライン･アクセス:	http://www.mdpi.com/1420-3049/23/7/1564